We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I Multiple-Ascending Dose (Japan) (MAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00538174
Recruitment Status : Completed
First Posted : October 2, 2007
Last Update Posted : March 23, 2015
Sponsor:
Information provided by (Responsible Party):
AstraZeneca